Keiko Tanaka, Youichi Ogawa, Shinji Shimada. Show Affiliations »
Abstract
Entities: Chemical Disease Gene
Mesh： See more » Diabetes Mellitus, Type 2/drug therapyDipeptidyl-Peptidase IV Inhibitors/administration & dosageDipeptidyl-Peptidase IV Inhibitors/adverse effectsDrug Eruptions/diagnosisDrug Eruptions/etiologyFemaleHumansHyperglycemia/drug therapyHypoglycemic Agents/therapeutic useMiddle AgedPruritus/chemically inducedPruritus/diagnosisPyrazines/administration & dosagePyrazines/adverse effectsSeverity of Illness IndexSitagliptin PhosphateTriazoles/administration & dosageTriazoles/adverse effects
Substances： See more » Dipeptidyl-Peptidase IV InhibitorsHypoglycemic AgentsPyrazinesTriazolesSitagliptin Phosphate
Year: 2011 PMID： 21981936 DOI： 10.1111/j.1346-8138.2011.01372.x
Source DB: PubMed Journal: J Dermatol ISSN： 0385-2407 Impact factor: 4.005